Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.
2.

EGFR-TKI, erlotinib, causes hypomagnesemia, oxidative stress, and cardiac dysfunction: attenuation by NK-1 receptor blockade.

Mak IT, Kramer JH, Chmielinska JJ, Spurney CF, Weglicki WB.

J Cardiovasc Pharmacol. 2015 Jan;65(1):54-61. doi: 10.1097/FJC.0000000000000163.

3.

Inhibition of neutral endopeptidase potentiates neutrophil activation during Mg-deficiency in the rat.

Mak IT, Kramer JH, Chmielinska JJ, Khalid MH, Landgraf KM, Weglicki WB.

Inflamm Res. 2008 Jul;57(7):300-5. doi: 10.1007/s00011-007-7186-z.

4.

Neutral endopeptidase inhibition enhances substance P mediated inflammation due to hypomagnesemia.

Weglicki WB, Chmielinska JJ, Tejero-Taldo I, Kramer JH, Spurney CF, Viswalingham K, Lu B, Mak IT.

Magnes Res. 2009 Sep;22(3):167S-173S.

5.
6.

d-Propranolol protects against oxidative stress and progressive cardiac dysfunction in iron overloaded rats.

Kramer JH, Spurney CF, Iantorno M, Tziros C, Chmielinska JJ, Mak IT, Weglicki WB.

Can J Physiol Pharmacol. 2012 Sep;90(9):1257-68. doi: 10.1139/y2012-091. Epub 2012 Aug 22.

7.

Activation of the neutrophil and loss of plasma glutathione during Mg-deficiency--modulation by nitric oxide synthase inhibition.

Mak IT, Dickens BF, Komarov AM, Wagner TL, Phillips TM, Weglicki WB.

Mol Cell Biochem. 1997 Nov;176(1-2):35-9.

PMID:
9406142
8.

Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P.

Sturiale S, Barbara G, Qiu B, Figini M, Geppetti P, Gerard N, Gerard C, Grady EF, Bunnett NW, Collins SM.

Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11653-8.

9.

Dietary magnesium intake influences circulating pro-inflammatory neuropeptide levels and loss of myocardial tolerance to postischemic stress.

Kramer JH, Mak IT, Phillips TM, Weglicki WB.

Exp Biol Med (Maywood). 2003 Jun;228(6):665-73.

PMID:
12773697
10.

Neutral endopeptidase modulates substance P-induced activation of human neutrophils.

Iwamoto I, Kimura A, Yamazaki H, Nakagawa N, Tomioka H, Yoshida S.

Int Arch Allergy Appl Immunol. 1990;93(2-3):133-8.

PMID:
1712001
11.

Prolonged inhibition of neutral endopeptidase 24.11 by sinorphan in stroke-prone spontaneously hypertensive rats.

Stasch JP, Knorr A, Wegner M, Hirth-Dietrich C.

Hypertens Res. 1995 Jun;18(2):137-43.

12.

The EGFR tyrosine kinase inhibitor tyrphostin AG-1478 causes hypomagnesemia and cardiac dysfunction.

Weglicki WB, Kramer JH, Spurney CF, Chmielinska JJ, Mak IT.

Can J Physiol Pharmacol. 2012 Aug;90(8):1145-9. doi: 10.1139/y2012-023. Epub 2012 May 30.

13.

Long-term treatment with neutral endopeptidase inhibitor improves cardiac function and reduces natriuretic peptides in rats with chronic heart failure.

Maki T, Nasa Y, Yamaguchi F, Yoshida H, Mori M, Takada T, Horikawa E, Okano K, Takeo S.

Cardiovasc Res. 2001 Aug 15;51(3):608-17.

PMID:
11476752
14.

Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.

Wegner M, Hirth-Dietrich C, Stasch JP.

Cardiovasc Res. 1996 Jun;31(6):891-8.

PMID:
8759244
16.

N-methyl-D-aspartate receptor blockade inhibits cardiac inflammation in the Mg2+-deficient rat.

Tejero-Taldo MI, Chmielinska JJ, Gonzalez G, Mak IT, Weglicki WB.

J Pharmacol Exp Ther. 2004 Oct;311(1):8-13. Epub 2004 May 28.

18.

Down-regulation and inactivation of neutral endopeptidase 24.11 (enkephalinase) in human neutrophils.

Erdös EG, Wagner B, Harbury CB, Painter RG, Skidgel RA, Fa XG.

J Biol Chem. 1989 Aug 25;264(24):14519-23.

19.

Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.

Trippodo NC, Robl JA, Asaad MM, Bird JE, Panchal BC, Schaeffer TR, Fox M, Giancarli MR, Cheung HS.

J Pharmacol Exp Ther. 1995 Nov;275(2):745-52.

PMID:
7473162
20.

NK-1 receptor desensitization and neutral endopeptidase terminate SP-induced pancreatic plasma extravasation.

Maa J, Grady EF, Kim EH, Yoshimi SK, Hutter MM, Bunnett NW, Kirkwood KS.

Am J Physiol Gastrointest Liver Physiol. 2000 Oct;279(4):G726-32.

Supplemental Content

Support Center